Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells

Chemical Research in Toxicology

Volumn 20, Issue 8, 2007, Pages 1120-1125

  Naranmandura, Hua ^a   Ibata, Kenji ^a   Suzuki, Kazuo T ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC ACID; ARSENIC TRIOXIDE; ARSINIC ACID DERIVATIVE; CACODYLIC ACID; DIMETHYLMONOTHIOARSINIC ACID; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LC 50; SQUAMOUS CELL CARCINOMA;

ARSENIC POISONING; ARSENICALS; CACODYLIC ACID; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; G1 PHASE; HUMANS; LETHAL DOSE 50; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; S PHASE; SKIN NEOPLASMS; TIME FACTORS;

ANIMALIA;

EID: 34548499361     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700103y     Document Type: Article

References (39)

1. National Research Council (1999) Arsenic in Drinking Water, National Academy Press, Washington, DC.
2. National Research Council (2001) Arsenic in Drinking Water 2001 Update, National Academy Press, Washington, DC.
3. Yamauchi, H., and Yamamura, Y. (1979) Dynamic change of inorganic arsenic and methylarsenic compounds in human urine after oral intake as arsenic trioxide. Ind. Health 17, 79-83.
4. Vahter, M., and Marafante, E. (1983) Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem.-Biol. Interact. 47, 29-44.
5. Mandal, B. K., and Suzuki, K. T. (2002) Arsenic round the world: A review. Talanta 58, 201-235.
6. Nakamuro, K., and Sayato, Y. (1981) Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic. Mutat. Res. 88, 73-80.
7. Nesnow, S., Roop, B. C., Lambert, G., Kadiiska, M., Mason, R. P., Cullen, W. R., and Mass, M. J. (2002) DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15, 1627-1634.
8. Wang, T. S., Chung, C. H., Wang, A. S., Bau, D. T., Samikkannu, T., Jan, K. Y., Cheng, Y. M., and Lee, T. C. (2002) Endonuclease III, formamidopyrimidine DNA glycosylase, and proteinase K additively enhance arsenic-induced DNA strand breaks in human cells. Chem. Res. Toxicol. 15, 1254-1258.
9. Kligerman, A. D., Doerr, C. L., Tennant, A. H., Harrington-Brock, K., Allen, J. W., Winkfield, E., Poorman-Allen, P., Kundu, B., Funasaka, K., Roop, B. C., Mass, M. J., and DeMarini, D. M. (2003) Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen. 42, 192-205.
10. Schwerdtle, T., Walter, I., Mackiw, I., and Hartwig, A. (2003) Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 24, 961-914.
11. 74As-arsenite or arsenate. Acta Pharmacol. Toxicol. 51, 253-265.
12. Shi, H., Hudson, L. G., Ding, W., Wang, S., Cooper, K. L., Liu, S., Chen, Y., Shi, X., and Liu, K. J. (2004) Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem. Res. Toxicol. 17, 871-878.
13. Hei, T. K., Liu, S. X., and Waldren, C. (1998) Mutagenicity of arsenic in mammalian cells: Role of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 95, 8103-8107.
14. Liu, F., and Jan, K. Y. (2000) DNA damage in arsenite and cadmium-treated bovine aortic endothelial cells. Free Radical Biol. Med. 28, 55-63.
15. Ding, W., Hudson, L. G., and Liu, K. J. (2005) Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol. Cell. Biochem. 279, 105-112.
16. Naranmandura, H., Suzuki, N., and Suzuki, K. T. (2006) Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 19, 1010-1018.
17. Marafante, E., Vahter, M., and Envall, J. (1985) The role of the methylation in the detoxication of arsenate in the rabbit. Chem.-Biol. Interact. 56, 225-238.
18. Gebel, T. W. (2002) Arsenic methylation is a process of detoxification through accelerated excretion. Int. J. Hyg. Environ. Health 205, 505-508.
19. Wei, M., Wanibuchi, H., Yamamoto, S., Li, W., and Fukushima, S. (1999) Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 20, 1873-1876.
20. Yoshida, K., Inoue, Y., Kuroda, K., Chen, H., Wanibuchi, H., Fukushima, S., and Endo, G. (1998) Urinary excretion of arsenic metabolites after long-term oral administration of various arsenic compounds to rats. J. Toxicol. Environ. Health, Part A 54, 179-192.
21. Hansen, H. R., Raab, A., Jaspars, M., Milne, B. F., and Feldmann, J. (2004) Sulfur-containing arsenical mistaken for dimethylarsinous acid [DMA-(III)] and identified as a natural metabolite in urine: Major implications for studies on arsenic metabolism and toxicity. Chem. Res. Toxicol. 17, 1086-1091.
22. Rami, R., Rumpler, A., Goessler, W., Vahter, M., Li, L., Ochi, T., and Francesconi, K. A. (2007) Thio-dimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh. Toxicol. Appl. Pharmacol. (in press).
23. Suzuki, K. T., Katagiri, A., Sakuma, Y., Ogra, Y., and Ohmichi, M. (2004) Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats. Toxicol. Appl. Pharmacol. 198, 336-344.
24. Naranmandura, H., Suzuki, N., Iwata, K., Hirano, K., and Suzuki, K. T. (2007) Arsenic metabolism and thioarsenicals in hamsters and rats. Chem. Res. Toxicol. 20, 616-624.
25. Aposhian, H. V., Gurzau, E. S., Le, X. C., Gurzau, A., Healy, S. M., Lu, X., Ma, M., Yip, L., Zakharyan, R. A., Maiorino, R. M., Dart, R. C., Tircus, M. G., Gonzalez-Ramirez, D., Morgan, D. L., Avram, D., and Aposhian, M. M. (2000) Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13, 693-697.
26. Mandal, B. K., Ogra, Y., and Suzuki, K. T. (2001) Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic affected areas in West Bengal, India. Chem. Res. Toxicol. 14, 371-378.
27. Okina, M., Yoshida, K., Kuroda, K., Wanibuchi, H., Fukushima, S., and Endo, G. (2004) Determination of trivalent methylated arsenicals in rat urine by liquid chromatography-inductively coupled plasma mass spectrometry after solvent extraction. J. Chromatogr., B 799, 209-215.
28. Wang, Z., Zhou, J., Lu, X., Gong, Z., and Le, X. C. (2004) Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Chem. Res. Toxicol. 17, 95-103.
29. Valenzuela, O. L., Borja-Aburto, V. H., Garcia-Vargas, G. G., Cruz-Gonzalez, M. B., Garcia-Montalvo, E. A., Calderon-Aranda, E. S., and Del Razo, L. M. (2005) Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect. 113, 250-254.
30. Suzuki, K. T., Iwata, K., Naranmandura, H., and Suzuki, N. (2007) Metabolic differences between two dimethylthioarsenicals in rats. Toxicol. Appl. Pharmacol. 218, 166-173.
31. Kuroda, K., Yoshida, K., Yoshimura, M., Endo, Y., Wanibuchi, H., Fukushima, S., and Endo, G. (2003) Microbial metabolite of dimethyl-arsinic acid is highly toxic and genotoxic. Toxicol. Appl. Pharmacol. 198, 345-353.
32. Suzuki, K. T., Mandal, B. K., Katagiri, A., Sakuma, Y., Kawakami, A., Ogra, Y., Yamaguchi, K., Sei, Y., Yamanaka, K., Anzai, M., Ohmichi, H., Takayama, H., and Aimi, N. (2004) Dimethylthioarsenicals as arsenic metabolites and their chemical preparation. Chem. Res. Toxicol. 17, 914-921.
33. Kitchin, K. T. (2001) Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172, 249-261.
34. Yamanaka, K., Kato, K., Mizoi, M., An, Y., Takabayashi, F., Nakano, M., Hoshino, M., and Okada, S. (2004) The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. Toxicol. Appl. Pharmacol. 198, 385-393.
35. Hughes, M. F., Kenyon, E. M., Edwards, B. C., Mitchell, C. T., Del Razo, L. M., and Thomas, D. J. (2003) Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate. Toxicol. Appl. Pharmacol. 191, 202-210.
36. Hernandez-Zavala, A., Cordova, E., Del Razo, L. M., Cebrian, M. E., and Garrido, E. (2005) Effects of arsenite on cell cycle progression in a human bladder cancer cell line. Toxicology 207, 49-57.
37. Hirano, S., Cui, X., Li, S., Kanno, S., Kobayashi, Y., Hayakawa, T., and Shraim, A. (2003) Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch. Toxicol. 77, 305-312.
38. Dopp, E., Hartmann, L. M., Florea, A. M., Von Recklinghausen, U., Pieper, R., Shokouhi, B., Rettenmeier, A. W., Hirner, A. V., and Obe, G. (2004) Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Toxicol. Appl. Pharmacol. 201, 156-165.
39. Thomas, D. J., Styblo, M., and Lin, S. (2001) The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176, 127-144.